OMRF’s Christopher Hoover became just the second Oklahoman in 30 years to earn a prestigious Kirschstein service award.
blood
Oklahoma researchers zero in on cause of blood disorder
New findings could help scientists develop treatments for the condition known as ITP.
OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
OMRF researcher tests new approach for treating deadly blood infection
Lupu’s findings were published in the Proceedings of the National Academy of Sciences.
Med-ucation: How smart are the drugs we take?
Have you ever wondered how pills do their job inside the body?
OMRF receives new grants to study blood clotting, ovarian cancer
The National Institutes of Health grants total nearly $2.1 million.
